Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform
Propeller Health, a digital health company dedicated to the management of asthma and COPD, announced that it has received 501(k) clearance from the FDA to connect patients using AstraZeneca’s Symbicort Inhaler to its digital health platform. The Propeller Health platform already connects to the majority of inhalers used by asthma and COPD patients, including those manufactured by Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Orion, as well as many generic equivalent inhalers. Propeller is a tool that helps asthma and COPD patients manage their condition in partnership with their...